Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Biotech
Roche reports pivotal MS win, but deaths add to safety questions
The discovery that more patients died on fenebrutinib than on the control drug has spurred further analyses by Roche.
Nick Paul Taylor
Mar 2, 2026 6:00am
Novartis jettisons ph. 1 cancer candidate after 0% efficacy
Feb 19, 2026 2:45pm
Roche unveils data behind BTK inhibitor's phase 3 MS win
Feb 9, 2026 7:00am
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Jan 6, 2026 4:30am
FDA rejects Sanofi MS drug, Corcept Cushing's syndrome therapy
Jan 2, 2026 7:10am
Sanofi's tolebrutinib woes pile up with FDA delay, trial miss
Dec 15, 2025 9:30am
